UBE2FP1: A Drug Target / Disease Biomarker (G100421436)

Target Name: UBE2FP1

NCBI ID: G100421436

UBE2FP1

Other Name(s): UBE2F pseudogene 1

UBE2FP1: A Drug Target / Disease Biomarker

UBE2FP1, also known as UBE2F1, is a protein that is expressed in the endoplasmic reticulum (ER) and is involved in the regulation of various cellular processes. UBE2FP1 has been identified as a potential drug target and a biomarker for various diseases, including cancer, neurodegenerative diseases, and neuropsychiatric disorders.

The UBE2FP1 protein is composed of 251 amino acids and has a calculated molecular weight of 31 kDa. It is localized to the endoplasmic reticulum, where it functions as a transmembrane protein that is involved in the regulation of various cellular processes, including protein synthesis, localization, and degradation. UBE2FP1 is known to play a role in the retrieval and transport of proteins to the ER, as well as in the regulation of protein stability and localization.

One of the key functions of UBE2FP1 is its role in the regulation of protein stability. UBE2FP1 has been shown to interact with various protein substrates, including polyhistone II, and to play a role in the regulation of their stability. This suggests that UBE2FP1 may be involved in the regulation of protein stability and localization in the ER, and that it may serve as a potential drug target or biomarker for diseases associated with changes in protein stability or localization.

Another function of UBE2FP1 is its role in the regulation of protein localization. UBE2FP1 is known to play a role in the regulation of protein localization to various cellular structures, including the ER, the mitochondria, and the endosomal system. This suggests that UBE2FP1 may be involved in the regulation of protein localization and may serve as a potential drug target or biomarker for diseases associated with changes in protein localization.

In addition to its functions in protein stability and localization, UBE2FP1 is also involved in the regulation of protein synthesis. UBE2FP1 has been shown to play a role in the regulation of protein synthesis by affecting the translation efficiency of UBE2FP1-containing mRNAs. This suggests that UBE2FP1 may be involved in the regulation of protein synthesis and may serve as a potential drug target or biomarker for diseases associated with changes in protein synthesis.

The potential drug target or biomarker properties of UBE2FP1 are due to its unique expression pattern and its involvement in various cellular processes that are important for the function of the cell. UBE2FP1 is highly expressed in the ER, which suggests that it may be involved in the regulation of protein stability and localization. Its involvement in the regulation of protein synthesis and localization also suggests that UBE2FP1 may be a potential drug target or biomarker for diseases associated with changes in these processes.

In conclusion, UBE2FP1 is a protein that is involved in various cellular processes that are important for the function of the cell. Its unique expression pattern and involvement in the regulation of protein stability, localization, and synthesis make it a potential drug target or biomarker for various diseases. Further research is needed to fully understand the role of UBE2FP1 in cellular processes and to determine its potential as a drug target or biomarker.

Protein Name: UBE2F Pseudogene 1

The "UBE2FP1 Target / Biomarker Review Report" is a customizable review of hundreds up to thousends of related scientific research literature by AI technology, covering specific information about UBE2FP1 comprehensively, including but not limited to:
•   general information;
•   protein structure and compound binding;
•   protein biological mechanisms;
•   its importance;
•   the target screening and validation;
•   expression level;
•   disease relevance;
•   drug resistance;
•   related combination drugs;
•   pharmacochemistry experiments;
•   related patent analysis;
•   advantages and risks of development, etc.
The report is helpful for project application, drug molecule design, research progress updates, publication of research papers, patent applications, etc. If you are interested to get a full version of this report, please feel free to contact us at BD@silexon.ai

More Common Targets